Association Between Potentially Inappropriate Medications From the Beers Criteria and the Risk of Unplanned Hospitalization in Elderly Patients

Annals of Pharmacotherapy

Volumn 48, Issue 1, 2014, Pages 6-16

  Price, Sylvie D ^a   Holman, C D'Arcy J ^a   Sanfilippo, Frank M ^a   Emery, Jon D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Australian elderly; Beers Criteria; case time control design; inappropriate prescribing; pharmaceutical claims; pharmacoepidemiology; unplanned hospitalization

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPARKINSON AGENT; ANTIRHEUMATIC AGENT; ANXIOLYTIC AGENT; BELLADONNA ALKALOID; CARDIOVASCULAR AGENT; DIAZEPAM; ESTROGEN; GASTROINTESTINAL AGENT; HYPNOTIC SEDATIVE AGENT; INDOMETACIN; IRON; LAXATIVE; LOOP DIURETIC AGENT; NEUROLEPTIC AGENT; NITROFURANTOIN; OXAZEPAM; PETHIDINE; PROMETHAZINE; PSYCHOSTIMULANT AGENT; TEMAZEPAM; THIORIDAZINE; UNINDEXED DRUG; URINARY TRACT ANTIINFECTIVE AGENT; URINARY TRACT SPASMOLYTIC AGENT;

AGED; ARTICLE; ATTRIBUTABLE RISK; AUSTRALIA; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; GERIATRIC PATIENT; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT PLANNING;

AUSTRALIAN ELDERLY; BEERS CRITERIA; CASE-TIME-CONTROL DESIGN; INAPPROPRIATE PRESCRIBING; PHARMACEUTICAL CLAIMS; PHARMACOEPIDEMIOLOGY; UNPLANNED HOSPITALIZATION;

AGED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; ODDS RATIO; RISK; WESTERN AUSTRALIA;

EID: 84892889799     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013504904     Document Type: Article

References (55)

1. Boparai MK,Korc-Grodzicki B.Prescribing for older adults.Mt Sinai J Med. 2011;78:613-626.
2. Wynne HA,Blagburn J.Drug treatment in an ageing population: practical implications.Maturitas. 2010;66:246-250.
3. Shi S,Morike K,Klotz U.The clinical implications of ageing for rational drug therapy.Eur J Clin Pharmacol. 2008;64:183-199.
4. Budnitz DS,Lovegrove MC,Shehab N,Richards CL.Emergency hospitalizations for adverse drug events in older Americans.N Engl J Med. 2011;365:2002-2012.
5. Runciman WB,Roughead EE,Semple SJ,Adams RJ.Adverse drug events and medication errors in Australia.Int J Qual Health Care. 2003;15:i49-i59.
6. Beers MH,Ouslander JG,Rollingher I,Reuben DB,Brooks J,Beck JC.Explicit criteria for determining inappropriate medication use in nursing-home residents.Arch Intern Med. 1991;151:1825-1832.
7. Beers MH.Explicit criteria for determining potentially inappropriate medication use by the elderly-an update.Arch Intern Med. 1997;157:1531-1536.
8. Fick DM,Cooper JW,Wade WE,Waller JL,Maclean JR,Beers MH.Updating the Beers Criteria for potentially inappropriate medication use in older adults-results of a US consensus panel of experts.Arch Intern Med. 2003;163:2716-2724.
9. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.J Am Geriatr Soc. 2012;60:616-631.
10. Jano E,Aparasu RR.Healthcare outcomes associated with Beers' Criteria: a systematic review.Ann Pharmacother. 2007;41:438-448.
11. Spinewine A,Schmader KE,Barber N, et al.Prescribing in elderly people 1-appropriate prescribing in elderly people: how well can it be measured and optimised?.Lancet. 2007;370:173-184.
12. Gallagher P,Barry P,O'Mahony D.Inappropriate prescribing in the elderly.J Clin Pharm Ther. 2007;32:113-121.
13. Landi F,Russo A,Liperoti R, et al.Impact of inappropriate drug use on physical performance among a frail elderly population living in the community.Eur J Clin Pharmacol. 2007;63:791-799.
14. Fick DM,Mion LC,Beers MH,Waller JL.Health outcomes associated with potentially inappropriate medication use in older adults.Res Nurs Health. 2008;31:42-51.
15. Gallagher PF,Barry PJ,Ryan C,Hartigan I,O'Mahony D.Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria.Age Ageing. 2008;37:96-101.
16. Lin HY,Liao CC,Cheng SH,Wang PC,Hsueh YS.Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases-experience in a Taiwanese medical setting.Drugs Aging. 2008;25:49-59.
17. Chen YC,Hwang SJ,Lai HY, et al.Potentially inappropriate medication for emergency department visits by elderly patients in Taiwan.Pharmacoepidemiol Drug Saf. 2009;18:53-61.
18. Chrischilles EA,VanGilder R,Wright K,Kelly M,Wallace RB.Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults.J Am Geriatr Soc. 2009;57:1000-1006.
19. Chan VT,Woo BKP,Sewell DD, et al.Reduction of suboptimal prescribing and clinical outcome for dementia patients in a senior behavioral health inpatient unit.Int Psychogeriatr. 2009;21:195-199.
20. Ruggiero C,Dell'Aquila G,Gasperini B, et al.Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents-the ULISSE project.Drugs Aging. 2010;27:747-758.
21. Stockl KM,Le L,Zhang SA,Harada ASM.Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly.Am J Manag Care. 2010;16:e1-e10.
22. Albert SM,Colombi A,Hanlon J.Potentially inappropriate medications and risk of hospitalization in retirees-analysis of a US retiree health claims database.Drugs Aging. 2010;27:407-415.
23. Dedhiya SD,Hancock E,Craig BA,Doebbeling CC,Thomas J.Incident use and outcomes associated with potentially inappropriate medication use in older adults.Am J Geriatr Pharmacother. 2010;8:562-570.
24. Akazawa M,Imai H,Igarashi A,Tsutani K.Potentially inappropriate medication use in elderly Japanese patients.Am J Geriatr Pharmacother. 2010;8:146-160.
25. Duckett SJ.Drug policy down under: Australia's Pharmaceutical Benefits Scheme.Health Care Financ Rev. 2004;25:55-67.
26. Lopert R.Evidence-based decision-making within Australia's Pharmaceutical Benefits Scheme.Issue Brief (Commonwealth Fund). 2009;60:1-13.
27. Harris MG,Harris RD.The Australian health system: continuity and change.J Health Hum Serv Admin. 1998;20:442-467.
28. Medicare Benefits Schedule Book. Canberra: Australian Government; 2008:.
29. Residential Aged Care in Australia 2007-08: A Statistical Overview. Canberra: Australian Institute of Health and Welfare; 138-141.
30. Holman CDJ,Bass AJ,Rouse IL,Hobbs MS.Population-based linkage of health records in Western Australia: development of a health services research linked database.Aust N Z J Public Health. 1999;23:453-459.
31. Canberra: Australian Government; 1991-2007.
32. Guidelines for ATC Classification and DDD Assignment 2007. Oslo, Norway: World Health Organization; 2006:.
33. Britt H,Miller G,Bayram C.The quality of data on general practice-a discussion of BEACH reliability and validity.Aust Fam Physician. 2007;36:36-40.
34. MIMS Australia. MIMS online. St Leonards, New South Wales: MIMS Australia;2008. https://www.mimsonline.com.au/Search/Search.aspx. Accessed 2008.
35. Guidelines for ATC Classification and DDD Assignment 2008. Oslo, Norway: World Health Organization; 2007:.
36. Greenblatt DJ.Elimination half-life of drugs: value and limitations.Annu Rev Med. 1985;36:421-427.
37. Birkett DJ.Pharmacokinetics made easy 3: half-life.Aust Prescriber. 1988;11:57-59.
38. Suissa S.The case-time-control design.Epidemiology. 1995;6:248-253.
39. Suissa S.The case-time-control design: further assumptions and conditions.Epidemiology. 1998;9:441-445.
40. Wang S,Linkletter C,Maclure M, et al.Future cases as present controls to adjust for exposure trend bias in case-only studies.Epidemiology. 2011;22:568-574.
41. Maclure M,Fireman B,Nelson JC, et al.When should case-only designs be used for safety monitoring of medical products?.Pharmacoepidemiol Drug Saf. 2012;21:50-61.
42. Quan H,Sundararajan V,Halfon P, et al.Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.Med Care. 2005;43:1130-1139.
43. Greenland S,Robins JM.Conceptual problems in the definition and interpretation of attributable fractions.Am J Epidemiol. 1988;128:1185-1197.
44. Greenland SModern Epidemiology. 3rd ed.Philadelphia: Lippincott Williams & Wilkins; 2008:283-302.Rothman KJGreenland SLash TL, ed. Philadelphia: Lippincott Williams & Wilkins; 283-302.
45. Australian Version of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). 9th Revision, Clinical Modification (ICD-9-CM). 1st and 2nd ed.Sydney, Australia: National Coding Centre; 1995, 1996.Sydney, Australia: National Coding Centre; 1996:.
46. The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM). 10th Revision, Australian Modification (ICD-10-AM). 1st to 4th ed.Sydney, Australia: National Centre for Classification in Health; 1998, 2000, 2002, 2004.Sydney, Australia: National Centre for Classification in Health; 1998 2004:.
47. Passarelli MC,Jacob-Filho W,Figueras A.Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.Drugs Aging. 2005;22:767-777.
48. Varallo FR,Capucho HC,Planeta CS,Mastroianni PdeC.Safety assessment of potentially inappropriate medications (PIM) use in older people and the factors associated with hospital admission.J Pharm Pharm Sci. 2011;14:283-290.
49. Gallagher P,O'Mahony D.STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' Criteria.Age Ageing. 2008;37:673-679.
50. Hamilton H,Gallagher P,Ryan C,Byrne S,O'Mahony D.Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.Arch Intern Med. 2011;171:1013-1019.
51. Greenland S.Confounding and exposure trends in case crossover and case time-control designs.Epidemiology. 1996;7:231-239.
52. Price SD,Holman CD,Sanfilippo FM,Emery JD.Use of case-time-control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly.Pharmacoepidemiol Drug Saf. 2013;22:1159-1170.
53. Principles of Exposure Measurement in Epidemiology: Collecting, Evaluating, and Improving Measures of Disease Risk Factors. 2nd ed.New York: Oxford University Press; 2008:65-95.White EArmstrong BKSaracci R, ed. New York: Oxford University Press; 65-95.
54. Wang SV,Gagne JJ,Glynn RJ,Schneeweiss S.Case-crossover studies of therapeutics design approaches to addressing time-varying prognosis in elderly populations.Epidemiology. 2013;24:375-378.
55. Marcum ZA,Hanlon JT.Commentary on the New American Geriatric Society Beers Criteria for potentially inappropriate medication use in older adults.Am J Geriatr Pharmacother. 2012;10:151-159.